Publications(FY 2013) | Urology Hokkaido University

2013-01.

Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L.
Combined inhibition of Weel and Hsp90 activates intrinsic apoptosis in cancer cells.
Cell Cycle. 11 (19) ; 3649-3655. 2012.

2013-02.

Akiyama K, Ohga N, Maishi N, Hida Y, Kitayama K, Kawamoto T, Osawa T, Suzuki Y, Shinohara N, Nonomura K, Shindoh M, Hida K.
The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.
Pathol Int. 63 (1) ; 37-44. 2013.

2013-03.

Abe T, Takada N, Shinohara N, Matsumoto R, Murai S, Sazawa A, Maruyama Satoru, Tsuchiya K, Kanzaki S, Nonomura K.
A comparison of 90-day complications between ileal conduit and neobladder reconstruction after radical cystectomy retrospective multi-institutional study in Japan.
Int J Ural. in press. 2013.

2013-04.

Abe T, Kitamura H, Ohara W, Matsumura N, Tsukamoto T, Fujioka T, Hara I, Murai S, Shinohara N, Nonomura K.
Outcome of metastasectomy for urothelial carcinoma: A multi-institutional retrospective study in Japan.
Int J Urol. in press. 2013.

2013-05.

Osawa T, Shinohara N, Maruyama S, Oba K, Abe T, Maru S, Takada N, Sazawa A, Nonomura K.
Long-term renal function outcomes in bladder cancer after radical cystectomy.
Urol J. 10 (1) ; 784·789. 2013.

2013-06.

Osawa T, Ohga N, Hida Y, Kitayama K, Aldyama K, Onodera Y, Fujita M, Shinohara N, Nonomura K, Shindoh M, Hida K.
Lysyl oxidase secreted by tumor endothelial cells promotes angiogenesis and metastasis.
BrJ Cancer. 109 (8) ; 2237-2247. 2013.

2013-07.

Ueda T, Uemura H, Tomita Y, Tsukamoto T, Kanayama H, Shinohara N, Tarazl J, Chen C, Kim S, Ozono S, Naito S, Akaza H.
Efficacy and safey of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from a randomized phase 3 AXIS trial.
Jpn J Clin Oncol. 43 (6) ; 616·628. 2013.

2013-08.

Kitta T, Tyagi V, Nanri M, Kiniwa M, Nonomura K, Yoshimura N.
Effects of propiverine hydrochloride, an anticholinergic agent, on urethral continence mechanisms and plasma catecholamine concentration in rats.
Int Urogynecol J. 24 (4) ; 683-8. 2013.

2013-09.

Kitta T.
Editorial Comment from Dr Kitta to Effect of intrathecal administration of E-series prostaglandin 1 receptor antagonist in a cyclophosphamide-induced cystitis rat model.
Int J Urol. 20 (2) ; 241. 2013.

2013-10.

Kitta T.
Editorial Comment to Pathophysiology of urinary incontinence in murine models.
Int J Urol. 20 (1) ; 71-72. 2013.

2013-11.

Kitta T, Mitsui. T, Kanno Y, Chiba H, Moriya K, Nonomura K.
Postoperative detrusor contractility temporarily decreases in patients undergoing pelvic organ prolapse surgery.
Int Urogynecol J. 24 ; S95. 2013.

2013-12.

Kohei N, Tanabe T, Horita S, Omoto K, Ishida H, Yamaguchi Y, Tanabe K.
Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model.
Kidney Int. 84;722-732. 2013.

2013-13.

Coma S, Allard-Ratick M, Akino T, van Meeteren LA, Mammoto A, Klagsbrun M.
GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.
Angiogenesis. 16 (4) ; 939-952. 2013.

2013-14.

Shinohara N, Maruyama S, Shimizu S, Nishioka K, Abe T, C-Hatanaka K, Oba K, Nonomura K, Shirato H.
Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer.
J Radiat Res. May9 [Epub ahead of print]. 2013.

2013-15.

Shimizu A, Nakayama H, Wang P, Konig C, Akino T, Sandlund J, Coma S, Italiano JE Jr, Mammoto A, Bielenberg DR, Klagsbrun M.
Netrin-1 promotes glioblastoma cellinvasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein.
J Biol Chem. 288 (4) ; 2210-2222. 2013.

2013-16.

Tanabe T, Morita K, Fujita H, Ogawa Y, Hirose T, Sasaki H, Iwami D, Hotta K, Nonomura K.
Long-term clinicopathological impact of calcineurin inhibitor cessation without specific cytoreductive induction in kidney transplantation.
Clin Transplant. in press. 2013.

2013-17.

Tsuchiya T, Ishida H, Tanabe T, Shimizu T, Honda K, Omoto K, Tanabe K.
Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation.
Transplantation. 96;198·204. 2013.

2013-18.

Naito S, Kinoshita H, Kondo T, Shinohara N, Kasahara T, Saito K, Takayama T, Masumori N, Takahashi W, Takahashi M, Terachi T, Ozono S, Naito S, Tomita Y.
Prognostic Factors of Metastatic Renal Cell Carcinoma Patients with Removed Metastases: A Multicentre Study of 559 Patients.
Urology. 82 (4) ; 846·51. 2013.

2013-19.

Panigrahy D, Kalish BT, Huang S, Bielenberg DR, Le HD, Yang J, Edin ML, Lee CR, Benny O, Mudge DK, Butterfield CE, Mammoto A, Mammoto T, Inceoglu B, Jenkins RL, Simpson MA, Al,ino T, Lih FB, Tomer KB, Ingber DE, Hammock ED, Falck JR,Manthati VL, Kaipainen A, D'Amore PA, Puder M, Zeldin DC, Kieran MW.
Epoxyeicosanoids promote organ and tissue regeneration.
Proc Natl Acad Sci USA. 110(33); 13528-13533. 2013.

2013-20.

Hirono M, Kobayashi M, Tsushima T, Obara W, Shinohara N, Ito K, Eto M, Takayama T, Fujii Y, Nishikido M, Kimura G, Kishida T, Takahashi M, Miyao N, Naya Y, Abe T, Fujioka T, Ito K, Naito S.
Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension before introducing molecular-targeted therapy: a multi-institutional retrospective study in Japan.
BMC Cancer. 13 (1) ; 447. 2013.

2013-21.

Hotta K, Fukasawa Y, Akimoto M, Tanabe T, Sasaki H, Fukuzawa N, Seki T, Togashi M, Harada H.
Tonsillectomy ameliorates histological damage of recurrent IgA nephropathy after kidney transplantation.
Nephrology. in press. 2013.

2013-22.

Miyajima N, Tsutsumi S, Sourbier C, Beebe K, Mollapour M, Rivas C, Yoshida S, Trepel J, Huang Y, Tatokoro M, Shinohara N, Nonomura K, Neckers L.
The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both both crizotinib-sensitive and crizotinib-resistant MET-driven tumor models.
Cancer Res. in press. 2013.

2013-23.

Morita K, Hirose T, Sasaki M, Masayoshi M, Tanabe T, Iwami D, Botta K, Fukuzawa N, Nonomura K.
Simultaneous ipsilateral native nephrectomy with kidney transplantation for the patients with polycystic kidney disease.
Urol List. 11 (1) ; 27-30. 2013.3.

2013-24.

Morita K, Iwami D, Fukuzawa N, Mitsui T, Sazawa A, Miyajima N, Taniguchi N, Nonomura K.
Retroperitoneal laparoscopic nephrectomy for the patients undergoing peritoneal dialysis.
Urol List. 11 (1) ; 31-34. 2013.

2013-25.

Yoshida S, Tsutsumi S, Muhlebach G, Sourbier C, Lee MJ, Lee S, Vartholomaiou E, Tatokoro M, Beebe K, Miyajima N, Mohney RP, Chen Y, Hasumi H, Xu W, Fukushima H, Nakamura K, Koga F, Kihara K, Trepel J, Picard D, Neckers L.
Molecular chaperone TRAPl regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.
Proc Natl Acad Sci USA. 110 (17) ; E1604·12. 2013.

2013-26.

Wakatsuki K, Sho M, Yamato I, Takayama T, Matsumoto S, Tanaka T, Migita K, Ito M, Hotta k, Nakajima Y.
Clinical impact of tumor-infiltrating CD45RO+ memory T cells on human gastoric cancer.
Oncol Rep. 29;1756-1762. 2013.